花旗:降呷哺呷哺(0520.HK)目標價至13.1港元 評級“買入”
花旗發表報告指,呷哺呷哺(00520.HK)管理層表示經過去年9月的疲弱後,10月及11月同店銷售錄增長強勁。雖然由於冬季相對温暖而令12月上旬的生意相對較淡,但管理層看到在12月下旬及今年1月至今的同店銷售增長有所改善。
該行估計,呷哺呷哺去年下半年的同店銷售已恢復至大致持平或略有增長,對比去年上半年為錄得1.9%下跌,預期在較容易的比較基礎下,集團今年上半年的同店銷售將進一步回升。
基於對其今年10倍企業價值倍數(EV/EBITDA)計,花旗下調對呷哺呷哺目標價,由14.2港元降至13.1港元,維持“買入”評級。該行認為,股份現價相當於今年企業價值倍數7.6倍,估值並不昂貴。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.